[1]
N. Albareda, J. Zeichner, and N. Rosenberg, “A Randomized Vehicle-Controlled Trial to Assess the Efficacy, Safety, and Tolerability of Ozenoxacin 1% Cream in 412 Patients 2 Months and Older with Impetigo”, J of Skin, vol. 1, no. 3.1, p. s103, Oct. 2017.